STOCKWATCH
·
Pharmaceuticals
Investment2 Feb 2026, 05:51 pm

Syschem India Ltd. Aims for 8000 TPA API Production, Reports 858% PAT Growth

AI Summary

Syschem India Ltd., incorporated in 1993, has been on a journey of growth and innovation. The company introduced new chemical products in 2001 and shifted its focus to a broader production of intermediates for key drug portfolios in 2011-12. In 2017-2018, the company transitioned its core focus to Antibiotics range. The company has reported a significant revenue growth of 65% and EBITDA growth of 300% in comparison to the last financial year. With a global footprint in three continents and a presence in over 10 countries, Syschem India Ltd. aims to expand its current facility to an aim of 8000 TPA. The company is committed to fostering a culture of collaboration, growth, and safety, and adopting sustainable practices across the entire value chain.

Key Highlights

  • Syschem India Ltd. reports 858% PAT growth in the last financial year
  • Company aims to expand its current facility to an aim of 8000 TPA
  • Shifted focus to a broader production of intermediates for key drug portfolios in 2011-12
  • Global footprint in three continents and a presence in over 10 countries
  • Committed to fostering a culture of collaboration, growth, and safety, and adopting sustainable practices
SYSCHEM
Pharmaceuticals
SYSCHEM (INDIA) LTD.

Price Impact